Login / Register

Oxford Peptide Labs-Logo
SHIPPED STRAIGHT FROM OUR FREEZER
24 MONTH SHELF LIFE
HPLC TESTED 99%+ PURITY
SHIPPED WITHIN 24 HOURS
BPC-157 - Oxford Peptide Labs
VIAL0001
International Orders
Test HPLC
OVER 80K+
BPC-157 - Oxford Peptide Labs
VIAL0001
International Orders
Test HPLC
OVER 80K+

BPC-157

£27.90

In stock

High-purity BPC-157 lyophilized powder for research into soft tissue regeneration, angiogenesis, and gastric cytoprotection mechanisms.

Description

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide comprised of 15 amino acids, derived from a protective protein found in human gastric juice. It has been extensively studied for its cytoprotective effects and its ability to accelerate the healing of soft tissue, including tendons, ligaments, and skeletal muscle. The peptide’s primary mechanism of action involves the modulation of the nitric oxide (NO) system and the stimulation of angiogenic growth factors such as VEGF (Vascular Endothelial Growth Factor).

Reviews

There are no reviews yet.

Be the first to review “BPC-157”

Your email address will not be published. Required fields are marked *

No more offers for this product!

General Inquiries

There are no inquiries yet.

Category Tags , , Brand:
  • Download COA here:
Download COA (PDF)

Please note if you have a different Batch ID please contact us for the latest COA.

Chemical Specifications:

  • Chemical Name: Glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl-L-valine

  • Synonyms: PL 14736, Bepecin, Pentadecapeptide BPC 157

  • CAS Number: 137525-51-0

  • Molecular Formula: C62H98N16O22

  • Molecular Weight: 1419.5 g/mol (Peptide only)

  • Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

  • Structure: Linear Pentadecapeptide

Description & Mechanism
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide comprised of 15 amino acids, derived from a protective protein found in human gastric juice. It has been extensively studied for its cytoprotective effects and its ability to accelerate the healing of soft tissue, including tendons, ligaments, and skeletal muscle. The peptide’s primary mechanism of action involves the modulation of the nitric oxide (NO) system and the stimulation of angiogenic growth factors such as VEGF (Vascular Endothelial Growth Factor).

  • Soft Tissue Repair: Research indicates efficacy in accelerating the healing of transected rat Achilles tendons and medial collateral ligaments by enhancing fibroblast migration.

  • Angiogenesis: Investigated for its ability to upregulate VEGFR2 expression and promote the formation of new blood vessels in ischemic tissues.

  • Gastrointestinal Health: Studied for cytoprotective properties against gastric ulcers, inflammatory bowel disease (IBD), and NSAID-induced enteropathy.

  • Nitric Oxide Modulation: Acts on the NO signaling pathway to regulate vascular tone and protect endothelial function.

  • Formulation: Lyophilized powder.

  • Storage: -20°C for powder, -80°C for reconstituted solution to maintain stability.

  • Reconstitution: Bacteriostatic water or sterile saline. Avoid repeated freeze-thaw cycles.

  • Purity: ≥99% (HPLC)

  • Grade: Research Grade

  • Appearance: White lyophilized powder

  • Solubility: Soluble in water and acetic acid.

For Research Use Only. Not for human consumption.

  • Regulatory Status: BPC-157 is currently listed on the WADA Prohibited List and is not approved by the FDA for clinical use in humans.

  • Safety Profile: While preclinical models show a high safety margin, potential interactions with dopaminergic and serotonergic systems have been noted in rodent studies.

  • Experimental Use: Investigational compound intended solely for laboratory research and development purposes.

  1. Sikiric, P., et al. (2018). “Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.” Current Neuropharmacology, 14(8), 857-865.

  2. Chang, C. H., et al. (2011). “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” Journal of Applied Physiology, 110(3), 774-780.

  3. Gwyer, D., et al. (2019). “Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.” Cell and Tissue Research, 377(2), 153-159.

  4. Vukojevic, J., et al. (2022). “Pentadecapeptide BPC 157 and the Central Nervous System.” Neural Regeneration Research, 17(3), 482-487.

In stock

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden.